Methodology

All entries for: EydisBio Inc.

July 11, 2025

EydisBio Inc.

Orphan Drug Designation

FDA orphan drug designation: treatment of malignant glioma

Disease Area: Rare Diseases
Source
Facebook Linkedin
Main Menu
Scroll to Top